Trials initiated in CEE and Russia fell 18 per cent year-on-year in 2009, ending a period of growth. Outsourcing-Pharma presents this rise and fall as an interactive visualisation.
ClinicalTrials.gov lists 2380 clinical trials which were initiated in 2008 in Central and Eastern Europe (CEE) and Russia. A year later, amid a downturn in the pharma market, clinical trial initiation fell to 1951.
Underpinning this decline were drops in clinical trial initiation in all major markets in CEE and Russia. For instance, trial initiation in Poland, the largest market in the region, fell by 12 per cent to 345.
Albania, Moldova, Montenegro and Slovenia were the only countries recording year-on-year growth in clinical trials in 2009. Of these, only Slovenia initiated more than 10 clinical trials. Trial initiation in Slovenia increased from 33 in 2008 to 40 a year later.
Data can be viewed here .
Below is a heat map showing clinical trial initiation per 1m people. Pressing play animates the changes in clinical trial concentration which took place in CEE and Russia from 2000 to 2009.